Letteratura scientifica selezionata sul tema "Hémorragie majeure"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Hémorragie majeure".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "Hémorragie majeure":
Svahn, J., T. H. Cho, L. Derex, L. Mechtouff e N. Nighoghossian. "Hémorragie sous-arachnoïdienne et anomalies vasculaires cérébrales multiples au cours d’une β-thalassémie majeure". Revue Neurologique 169, n. 3 (marzo 2013): 266–68. http://dx.doi.org/10.1016/j.neurol.2012.09.015.
Nendaz, M. R., e A. Perrier. "L’impact clinique d’une hémorragie majeure ne doit pas être sous-estimé et doit être mis en balance avec le bénéfice attendu d’un traitement anticoagulant instauré pour maladie thromboembolique". Revue des Maladies Respiratoires 21 (giugno 2004): 94–95. http://dx.doi.org/10.1016/s0761-8425(04)71994-4.
Fraisse, T., L. Hery, F. Samou, V. Rieu, M. Ruivard, A. Buisson, O. Tournilhac, J. E. Kahn e S. Trouillier. "Éosinophilie majeure révélant une rectocolite hémorragique". La Revue de Médecine Interne 35 (giugno 2014): A152—A153. http://dx.doi.org/10.1016/j.revmed.2014.03.251.
Otesile, E. B., A. T. P. Ajuwape, S. O. Odemuyiwa, S. O. Akpavie, A. K. Olaifa, G. N. Odaibo, O. D. Olaleye e A. I. Adetosoye. "Enquête expérimentale et sur le terrain d’un foyer de peste porcine africaine au Nigeria". Revue d’élevage et de médecine vétérinaire des pays tropicaux 58, n. 1-2 (1 gennaio 2005): 21. http://dx.doi.org/10.19182/remvt.9935.
MAZARI, Fettouma. "The place of eye exam in the follow-up of the arterial hypertension". Batna Journal of Medical Sciences (BJMS) 6, n. 1 (1 luglio 2019): 77–81. http://dx.doi.org/10.48087/bjmscr.2019.6124.
Brémaud, Marc, Muriel Giansily-Blaizot, Lamisse Mansour, Fabien Lasue, Xavier Cassard e Pierre Sié. "Déficit constitutionnel en facteur VII et chirurgie orthopédique majeure : entre risque hémorragique et risque thrombotique". Anesthésie & Réanimation 1, n. 4 (luglio 2015): 360–63. http://dx.doi.org/10.1016/j.anrea.2015.01.006.
de Fourmestraux, Claire, Lise Gross e Emeline Jordan. "Complications associées aux chirurgies urogénitales chez la jument". Le Nouveau Praticien Vétérinaire équine 16 (ottobre 2022): 82–92. http://dx.doi.org/10.1051/npvequi/2023009.
Oger, E., M. A. Botrel, C. Juchault e J. Bouget. "Sensibilité et spécificité d’un algorithme basé sur des données médico-administratives pour identifier les patients hospitalisés pour hémorragies majeures". Revue d'Épidémiologie et de Santé Publique 68 (marzo 2020): S10—S11. http://dx.doi.org/10.1016/j.respe.2020.01.021.
El Alaoui, Mustapha Zine, Alexandre Guy, Loubna Khalki, Youness Limami, Ali Benomar, Nabil Zaid, Yahia Cherrah, Hassan Mekhfi, Rachida Cadi e Younes Zaid. "Antiplaquettaires actuels, en cours de développement et cibles thérapeutiques". médecine/sciences 36, n. 4 (aprile 2020): 348–57. http://dx.doi.org/10.1051/medsci/2020061.
Miot, S., A. T. Marteau, G. Simard e C. Lavigne. "Accident hémorragique sous antagonistes de la vitamine K: adaptation de la détermination de l’International Normalized Ratio (INR) dans les hypertriglycéridémies majeures". La Revue de Médecine Interne 31, n. 1 (gennaio 2010): 60–62. http://dx.doi.org/10.1016/j.revmed.2008.12.012.
Tesi sul tema "Hémorragie majeure":
Moussa, Mouhamed Djahoum. "Déterminants cliniques, physiopathologiques et pronostics associés aux complications liées à l’hémostase au cours des assistances circulatoires de courte durée à pompe centrifuge". Electronic Thesis or Diss., Université de Lille (2022-....), 2022. http://www.theses.fr/2022ULILS055.
The purpose of this dissertation is to characterize hemostasis-related complications in patients supported by peripheral VA-ECMO to improve their prevention and to optimize the antithrombotic therapeutic approaches in use. In a first study, we qualitatively and quantitatively described the composition of thrombi collected from the VA-ECMO circuits. We observed that these thrombi are mainly made of VWF, fibrin and in a lesser proportion of platelets and RBCs. Our quantitative approach also allowed us to demonstrate the presence of NETs while there was no active septic, confirming the possibility of aseptic NETosis under VA-ECMO. By hierarchical cluster analysis, we identified 2 types of thrombi, each of which may be related to a different mechanism of formation. In this study, the location of thrombi on the VA-ECMO circuit did not impact their compositions, highlighting the heterogeneity of thrombi formed within VA-ECMO and the multifactorial mechanisms that support thrombosis in this setting. In a second study, we compared the performance of surface coatings on VA-ECMO circuits to reduce thrombinoformation and its clinical consequences. Two of the most used coatings in daily practice were compared: the phosphorylcholin-based coating and the polysaccharide-albumin-based coating. We observed a higher rate of thrombotic complications in the phosphorylcholin group without any excess bleeding events or mortality in either group. In addition, compared with thrombi from phosphorylcholin-coated circuit junctions, those from polysaccharide-albumin-coated circuits were poorer in VWF. Our work suggests that the level of anticoagulation should be modulated according to the type of coating of the ECMO circuit.The aim of our third study was to identify the most relevant bleeding events that may guide clinical decision-making for more aggressive clinical management and a greater investment in research. To this end, we compared the association between 3 bleeding classifications with 28-day mortality. The ELSO definition already in use and the BARC classification classes ≥ type 2 were associated with 28-day mortality and thus retained as definitions of major bleeding. Laboratory parameters that are predictors major bleeding according to the ELSO definition were decreased fibrinogen, platelet count, and hemoglobin at cannulations. Body mass index and postcardiotomy etiology were also predictive of ELSO major bleeding. In an additional work related to the topic of the thesis, we studied two of the most used laboratory tests for the monitoring of systemic heparin during VA-ECMO, the APTT and the Anti-Xa activity, to identify the most relevant. First, we studied the relationship between these two tests and then analyzed in a second objective the impact of biological influencing factors on this relationship. Next, we determined their associations with thrombotic and hemorrhagic complications. Although linearly associated, the rate of discordance between their measurements was 39 % for an Anti-Xa reference range of 0.3 - 0.7 IU/mL. Neither APTT nor Anti-Xa was associated with thrombotic or bleeding complications. Taken together, our results highlight the heterogeneity of thrombi from peripheral VA-ECMO, the involvement of numerous causal factors that underline thrombotic and hemorrhagic complications, both not predictable by routine tests. Finally, our work underscored the need for new approaches in thrombotic or hemorrhagic complications management with targets set at an individual level considering both patient and ECMO circuit characteristics
Casolla, Barbara. "Pronostic vasculaire au long cours des patients après une hémorragie intracérébrale". Thesis, Lille 2, 2019. http://www.theses.fr/2019LIL2S026.
Background: Spontaneous (non-traumatic) intracerebral hemorrhage (ICH) is the mostdramatic type of stroke being responsible for the majority of mortality and stroke related disability. Survivors are at high risk of major vascular events, nevertheless, data on long-term prognosis after ICH are scarce. The main objective was to study long term cerebral and extra-cerebral vascular prognosis after ICH.Methods: We included patients from the PITCH (Prognosis of Intra Cerebral Haemorrhage) cohort which is a prospective and observational study that included consecutive adults admitted at the Lille University Hospital for spontaneous ICH between 2004 and 2009. We aimed to determine (i) cumulative incidence of major ischemic and hemorrhagic vascular events and their clinical and radiological predictors;(ii) the prevalence of cortical superficial siderosis (cSS) and its associated factors; (iii) the impact of cerebral microbleeds on ICH recurrence.Results: We showed that ICH survivors are at high risk of major cerebral and extracerebralvascular events. Ischemic risk overwhelmed the hemorrhagic one on long term,particularly in deep index ICH. Concerning recurrent ICH, we found that in our cohort,one out of five patients had cSS on baseline MRI and its presence was a strong predictorof recurrent ICH, suggesting the implication of underlying cerebral amyloid angiopathy.Global burden of microbleeds was also associated with higher rate of ICH recurrence.Conclusion: These findings have immediate clinical relevance and suggest that ICH survivors should benefit of a long-term and multidisciplinary follow-up. These results may also provide additional information on the risk of major ischemic and hemorrhagicevents after ICH and on radiological predictors of recurrence risk